Unternehmen Quest Diagnostics Incorporated
Aktien
904533
US74834L1008
DGX
Gesundheitspflege Einrichtungen
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
125.9 USD | -0.84% | -3.16% | -8.68% |
11.04. | John Chevedden reicht ein Exempt Solicitation Statement bei der Securities and Exchange Commission ein | CI |
05.04. | Quest Diagnostics erhält Aktionärsantrag von John Chevedden | CI |
Kurzporträt
- Tests und diagnostische Dienstleistungen (97,3%): klinische Routinetests, Gentests und fortgeschrittene diagnostische und anatomisch-pathologische Dienstleistungen;
- Sonstige (2,7%).
Mitarbeiterzahl: 44 000
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Diagnostic Information Services
97,0
%
| 9 609 | 97,2 % | 8 976 | 97,0 % | -6.59% |
All Other
3,0
%
| 274 | 2,8 % | 276 | 3,0 % | +0.73% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 883 | 100,0 % | 9 252 | 100,0 % | -6.38% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 01.04.13 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 11.07.22 |
Kristin Wallace
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 18.02.19 | |
Shawn Bevec
IRC | Investor Relations Contact | - | - |
Sean Mersten
SEC | Corporate Secretary | - | - |
Mark Delaney
PRN | Corporate Officer/Principal | - | 01.03.22 |
Michael Deppe
AUD | Comptroller/Controller/Auditor | 59 | 01.01.98 |
Alyssa Waxenberg
PRN | Corporate Officer/Principal | 53 | 01.01.21 |
Doug Lang
PRN | Corporate Officer/Principal | - | 01.04.13 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 18.02.19 |
Timothy Ring
BRD | Director/Board Member | 67 | 07.12.11 |
Gail Wilensky
BRD | Director/Board Member | 80 | 01.01.97 |
Gary M. Pfeiffer
BRD | Director/Board Member | 74 | 01.12.04 |
Timothy Main
BRD | Director/Board Member | 66 | 13.01.14 |
Vicky Gregg
BRD | Director/Board Member | 69 | 22.07.14 |
Tracey Doi
BRD | Director/Board Member | 63 | 17.08.21 |
Wright Lassiter
BRD | Director/Board Member | 60 | 12.03.20 |
James Davis
CEO | Chief Executive Officer | 61 | 01.04.13 |
Luis A. Diaz
BRD | Director/Board Member | 53 | 17.05.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 162 056 065 | 110 582 365 ( 68,24 %) | 51 000 000 ( 31,47 %) | 68,24 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. |
Biotechnology
|
Quest Diagnostics India Pvt Ltd.
Quest Diagnostics India Pvt Ltd. Medical/Nursing ServicesHealth Services Quest Diagnostics India Pvt Ltd. provides pathology and clinical laboratory testing services. It offers employee life cycle approach, pre-employment screening, drug testing solutions, occupational exposure screening and monitoring blueprint for wellness driving healthy behavior & outcomes. The company is headquartered in Gurgaon, India. |
Medical/Nursing Services
|
Quest Diagnostics HTAS India Pvt Ltd.
|
Sektor
Umsatz nach Geschäftsbereich
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-8.68% | 13.98 Mrd. | |
-12.12% | 87.46 Mrd. | |
+9.72% | 78.56 Mrd. | |
+10.85% | 29.37 Mrd. | |
-12.25% | 16.78 Mrd. | |
-5.45% | 16.01 Mrd. | |
+0.92% | 12.31 Mrd. | |
-30.35% | 12.07 Mrd. | |
+20.38% | 11.06 Mrd. | |
-5.53% | 11.4 Mrd. |
- Börse
- Aktien
- 904533 Aktie
- Unternehmen Quest Diagnostics Incorporated